Question 1

What is the catalog number for 8- (Furan-2-yl) -2-thioxo-1,2-dihydro-H-pyrazolo[1,5-d][1,2,4]triazinone?

Accepted Answer

The catalog number for 8- (Furan-2-yl) -2-thioxo-1,2-dihydro-H-pyrazolo[1,5-d][1,2,4]triazinone is 439928.

Question 2

What sizes are available for 8- (Furan-2-yl) -2-thioxo-1,2-dihydro-H-pyrazolo[1,5-d][1,2,4]triazinone?

Accepted Answer

8- (Furan-2-yl) -2-thioxo-1,2-dihydro-H-pyrazolo[1,5-d][1,2,4]triazinone is available in the following size(s): 25 mg, 50 mg.

Question 3

How many pack sizes does 8- (Furan-2-yl) -2-thioxo-1,2-dihydro-H-pyrazolo[1,5-d][1,2,4]triazinone come in?

Accepted Answer

8- (Furan-2-yl) -2-thioxo-1,2-dihydro-H-pyrazolo[1,5-d][1,2,4]triazinone is available in 2 different pack sizes.

Question 4

Is 8- (Furan-2-yl) -2-thioxo-1,2-dihydro-H-pyrazolo[1,5-d][1,2,4]triazinone in stock?

Accepted Answer

8- (Furan-2-yl) -2-thioxo-1,2-dihydro-H-pyrazolo[1,5-d][1,2,4]triazinone is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

8- (Furan-2-yl) -2-thioxo-1,2-dihydro-H-pyrazolo[1,5-d][1,2,4]triazinone

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

RET Proto-oncogene (RET/2662), 1mg/mL

CD3e (T-Cell Marker) (rC3e/2479), CF405S conjugate, 0.1mg/mL

EGFRvIII (Epidermal Growth Factor Receptor, Variant III) (GFR/2600R), CF647 conjugate, 0.1mg/mL

MiTF (Microphthalmia Transcription Factor) (C5/D5), 0.2mg/mL

CD54 (W-CAM-1; same as Wehi-CAM-1 or 1H4), CF640R conjugate, 0.1mg/mL

HCG-beta (hCGb/459), CF740 conjugate, 0.1mg/mL